202 related articles for article (PubMed ID: 26512929)
1. Topical treatment of actinic keratosis with 3.0% diclofenac in 2.5% hyaluronan gel: review of the literature about the cumulative evidence of its efficacy and safety.
Javor S; Cozzani E; Parodi A
G Ital Dermatol Venereol; 2016 Jun; 151(3):275-80. PubMed ID: 26512929
[TBL] [Abstract][Full Text] [Related]
2. Diclofenac sodium 3% gel for the management of actinic keratosis: 10+ years of cumulative evidence of efficacy and safety.
Martin GM; Stockfleth E
J Drugs Dermatol; 2012 May; 11(5):600-8. PubMed ID: 22527428
[TBL] [Abstract][Full Text] [Related]
3. An open study to assess the efficacy and safety of topical 3% diclofenac in a 2.5% hyaluronic acid gel for the treatment of actinic keratoses.
Rivers JK; McLean DI
Arch Dermatol; 1997 Oct; 133(10):1239-42. PubMed ID: 9382562
[TBL] [Abstract][Full Text] [Related]
4. Topical diclofenac: new preparation. Moderate efficacy in actinic keratosis.
Prescrire Int; 2004 Aug; 13(72):138-9. PubMed ID: 15532138
[TBL] [Abstract][Full Text] [Related]
5. Evidence for field cancerisation treatment of actinic keratoses with topical diclofenac in hyaluronic acid.
Ulrich M; Pellacani G; Ferrandiz C; Lear JT
Eur J Dermatol; 2014; 24(2):158-67. PubMed ID: 24721544
[TBL] [Abstract][Full Text] [Related]
6. Diclofenac Sodium 3% in Hyaluronic Acid 2.5% Gel Significantly Diminishes the Actinic Keratosis Area and Severity Index.
Schmitz L; Gupta G; Segert MH; Kost R; Sternberg J; Gambichler T; Stockfleth E; Dirschka T
Skin Pharmacol Physiol; 2018; 31(4):206-211. PubMed ID: 29791916
[TBL] [Abstract][Full Text] [Related]
7. Results of a randomized, placebo-controlled safety and efficacy study of topical diclofenac 3% gel in organ transplant patients with multiple actinic keratoses.
Ulrich C; Johannsen A; Röwert-Huber J; Ulrich M; Sterry W; Stockfleth E
Eur J Dermatol; 2010; 20(4):482-8. PubMed ID: 20507841
[TBL] [Abstract][Full Text] [Related]
8. Topical 3.0% diclofenac in 2.5% hyaluronic acid gel induces regression of cancerous transformation in actinic keratoses.
Dirschka T; Bierhoff E; Pflugfelder A; Garbe C
J Eur Acad Dermatol Venereol; 2010 Mar; 24(3):258-63. PubMed ID: 19709346
[TBL] [Abstract][Full Text] [Related]
9. Topical 3% diclofenac in 2.5% hyaluronic acid gel: a review of its use in patients with actinic keratoses.
Jarvis B; Figgitt DP
Am J Clin Dermatol; 2003; 4(3):203-13. PubMed ID: 12627996
[TBL] [Abstract][Full Text] [Related]
10. Open label randomized study comparing 3 months vs. 6 months treatment of actinic keratoses with 3% diclofenac in 2.5% hyaluronic acid gel: a trial of the German Dermatologic Cooperative Oncology Group.
Pflugfelder A; Welter AK; Leiter U; Weide B; Held L; Eigentler TK; Dirschka T; Stockfleth E; Nashan D; Garbe C;
J Eur Acad Dermatol Venereol; 2012 Jan; 26(1):48-53. PubMed ID: 21414035
[TBL] [Abstract][Full Text] [Related]
11. Phase IV, open-label assessment of the treatment of actinic keratosis with 3.0% diclofenac sodium topical gel (Solaraze).
Nelson C; Rigel D; Smith S; Swanson N; Wolf J
J Drugs Dermatol; 2004; 3(4):401-7. PubMed ID: 15303784
[TBL] [Abstract][Full Text] [Related]
12. Treatment of actinic keratosis through inhibition of cyclooxygenase-2: Potential mechanism of action of diclofenac sodium 3% in hyaluronic acid 2.5.
Thomas GJ; Herranz P; Cruz SB; Parodi A
Dermatol Ther; 2019 May; 32(3):e12800. PubMed ID: 30523664
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic and pharmacodynamic evaluation of ingenol mebutate for the treatment of actinic keratosis.
Stockfleth E; Bastian M
Expert Opin Drug Metab Toxicol; 2018 Sep; 14(9):911-918. PubMed ID: 30074409
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the efficacy and tolerability of 3% diclofenac sodium gel and 5% imiquimod cream in the treatment of actinic keratosis.
Kose O; Koc E; Erbil AH; Caliskan E; Kurumlu Z
J Dermatolog Treat; 2008; 19(3):159-63. PubMed ID: 18569272
[TBL] [Abstract][Full Text] [Related]
15. A single-arm, open-label efficacy and tolerability study of diclofenac sodium 3% gel for the treatment of actinic keratosis of the upper and lower lip.
Nelson CG; Spencer J; Nelson CG
J Drugs Dermatol; 2007 Jul; 6(7):712-7. PubMed ID: 17763595
[TBL] [Abstract][Full Text] [Related]
16. Phase IV head-to-head randomized controlled trial comparing ingenol mebutate 0·015% gel with diclofenac sodium 3% gel for the treatment of actinic keratosis on the face or scalp.
Stockfleth E; Harwood CA; Serra-Guillén C; Larsson T; Østerdal ML; Skov T
Br J Dermatol; 2018 Feb; 178(2):433-442. PubMed ID: 29030864
[TBL] [Abstract][Full Text] [Related]
17. The safety of diclofenac for the management and treatment of actinic keratoses.
Iraji F; Siadat AH; Asilian A; Enshaieh S; Shahmoradi Z
Expert Opin Drug Saf; 2008 Mar; 7(2):167-72. PubMed ID: 18324879
[TBL] [Abstract][Full Text] [Related]
18. Topical diclofenac 3% gel plus cryotherapy for treatment of multiple and recurrent actinic keratoses.
Mastrolonardo M
Clin Exp Dermatol; 2009 Jan; 34(1):33-5. PubMed ID: 18616726
[TBL] [Abstract][Full Text] [Related]
19. Comparison of topical 3% diclofenac sodium gel and 5% imiquimod cream for the treatment of actinic keratoses.
Akarsu S; Aktan S; Atahan A; Koç P; Özkan S
Clin Exp Dermatol; 2011 Jul; 36(5):479-84. PubMed ID: 21418281
[TBL] [Abstract][Full Text] [Related]
20. Three percent diclofenac in 2.5% hyaluronan gel in the treatment of actinic keratoses: a meta-analysis of the recent studies.
Pirard D; Vereecken P; Mélot C; Heenen M
Arch Dermatol Res; 2005 Nov; 297(5):185-9. PubMed ID: 16235081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
